RecruitingNCT06533410

Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Enrollment

59 participants

Start Date

May 21, 2024

Study Type

OBSERVATIONAL

Conditions

Fibromyalgia

Summary

This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that for people with fibromyalgia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTThe FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

Locations(1)

Guang'anmen Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06533410

Related Trials

Physiotherapy Methods for Fibromyalgia

NCT074256521 location

Analgesic Response to Opioids in Patients With Fibromyalgia After Conventional Acupuncture Versus Sham Acupuncture

NCT065711101 location